NeuroOne Medical Technologies Corporation Financial Ratios — NMTC

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-230.81	-123.77	-149.61	-348.39	-91.34
Return on Assets (%)	-240.24	-186.52	-3,719.29	-9,929.86	-6,153.99	-12.59	-1,004.74	- -	-1,805.1	-515.46	-156.69	-96.33	-113.38	-182.93	-44.63
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	60.39	100	100	100	100	- -	- -	- -	- -	- -	-54.87	-41.36	23.38	31.27	56.51
EBITDA Margin (%)	-508.11	-1,491.1	-2,009.05	-4,646.05	-4,166.44	- -	- -	- -	- -	- -	-5,690.54	-5,790.85	-602.12	-337.11	-43.58
Operating Margin (%)	-508.11	-1,491.1	-2,009.05	-4,646.05	-4,166.44	- -	- -	- -	- -	- -	-5,735.86	-5,860.15	-612.32	-344.26	-46.46
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	228.57	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-511.37	-1,515.74	-2,446.28	-4,688.75	-4,166.44	- -	- -	- -	- -	- -	-5,584.28	-5,841.95	-607.42	-356.74	-39.63
Profit Margin (%)	-511.37	-1,515.74	-2,446.28	-4,688.75	-8,472.1	- -	- -	- -	- -	- -	-5,584.28	-5,841.95	-607.42	-356.74	-39.63
Net Income to Common Margin (%)	-511.37	-1,515.74	-2,446.28	-4,688.75	-8,472.1	- -	- -	- -	- -	- -	-5,584.28	-5,841.95	-607.42	-356.74	-39.63
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-230.81	-123.77	-149.61	-348.39	-91.34

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Total Debt	- -	- -	- -	- -	- -	- -	2	2	- -	1	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	2	2	- -	1	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	-1.24	-1.12	- -	-0.44	-8.44	-0.79	- -	- -	-0.27	-0.03	-0.02	-0.02	-0.02	-0.07
Net Debt/EBITDA	0.5	-1.16	-1.09	0.01	-0.44	7.57	-0.78	- -	0.05	0.62	0.68	0.82	0.45	0.13	1.66
Total Debt/EBIT	- -	-1.24	-1.12	- -	-0.44	-8.44	-0.79	- -	- -	-0.27	-0.03	-0.02	-0.02	-0.02	-0.06
Net Debt/EBIT	0.5	-1.16	-1.09	0.01	-0.44	7.57	-0.78	- -	0.04	0.62	0.68	0.81	0.45	0.12	1.55
EBITDA to Interest Expense	-155.84	-60.5	- -	-108.83	-2.21	- -	-2.19	- -	-20.33	-0.65	-3,320.49	- -	- -	-50.83	-11.87
EBITDA-CapEx/Interest Expense	-155.84	-60.5	- -	-108.83	-2.21	- -	-2.26	- -	-20.77	-0.66	-3,342.46	- -	- -	-51.36	-12.11
EBIT to Interest Expense	-155.84	-60.5	- -	-108.83	-2.21	- -	-2.2	- -	-20.43	-0.65	-3,346.94	- -	- -	-51.91	-12.65
Interest Expense	- -	- -	- -	- -	- -	- -	1	- -	- -	8	- -	- -	- -	- -	- -
Common Equity/Total Assets	-23.66	-1,541.77	-5,769.71	-17,262.93	-4,433.73	-35.17	-2,014.77	-2,009.84	-232.36	43.41	82.56	74.9	77.18	15.31	65.57
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.31	3.1	1.24	0.88	23.65	2.02
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.51	2.95	1.22	0.86	17.96	1.95
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.34	2.56	0.93	0.68	3.62	1.33
Total Debt/Equity (%)	- -	-98.63	-92.44	- -	-16.71	-103.37	-48.07	-38.14	- -	63.86	4.82	2.11	2.95	31.65	3.77
Total Debt/Capital (%)	- -	-7,173	-1,222.17	- -	-20.07	3,065.58	-92.58	-61.67	- -	38.97	4.6	2.07	2.87	24.04	3.64
Total Debt/Total Assets (%)	- -	1,520.57	5,333.33	- -	740.97	36.36	968.59	766.65	- -	27.72	3.98	1.58	2.28	4.84	2.47
Net Debt to Equity	422.67	-92.14	-90.7	0.58	-16.71	92.79	-47.55	-37.84	21.07	-146.61	-105.3	-84.96	-85.17	-177.62	-92.9
Net Debt/Capital (%)	80.87	-1,172.1	-975.67	0.58	-20.07	48.13	-90.66	-60.88	17.4	465.43	21,721.47	-495.49	-478.94	386.39	-854.47
EBITDA	- -	- -	- -	- -	- -	- -	-3	- -	-6	-5	-10	-10	-12	-12	-4
EBITDA-CapEx	- -	- -	- -	- -	- -	- -	-3	- -	-6	-5	-10	-10	-12	-12	-4
Operating Income (Loss)	- -	- -	- -	- -	- -	- -	-3	- -	-6	-5	-10	-10	-12	-12	-4

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Cash Ratio	2.99	0.06	0.02	0.01	- -	0.77	0.01	- -	0.15	1.71	5.84	3.6	2.97	0.66	2.85
Current Ratio	2.99	0.06	0.02	0.01	0.02	0.85	0.01	- -	0.17	1.76	6.17	3.93	4.08	2.09	4.44
Quick Ratio	2.99	0.06	0.02	0.01	- -	0.77	0.01	- -	0.15	1.71	5.88	3.61	2.97	0.74	3.4
CFO/Avg Current Liab	-7.24	-1.2	-1.02	-0.79	-0.51	-0.06	-0.92	- -	-1.94	-1.66	-4.86	-3.51	-5.27	-5.5	-1.26
Common Equity/Total Assets	-23.66	-1,541.77	-5,769.71	-17,262.93	-4,433.73	-35.17	-2,014.77	-2,009.84	-232.36	43.41	82.56	74.9	77.18	15.31	65.57
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.31	3.1	1.24	0.88	23.65	2.02
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.51	2.95	1.22	0.86	17.96	1.95
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.34	2.56	0.93	0.68	3.62	1.33
Total Debt/Equity (%)	- -	-98.63	-92.44	- -	-16.71	-103.37	-48.07	-38.14	- -	63.86	4.82	2.11	2.95	31.65	3.77
Total Debt/Capital (%)	- -	-7,173	-1,222.17	- -	-20.07	3,065.58	-92.58	-61.67	- -	38.97	4.6	2.07	2.87	24.04	3.64
Total Debt/Total Assets (%)	- -	1,520.57	5,333.33	- -	740.97	36.36	968.59	766.65	- -	27.72	3.98	1.58	2.28	4.84	2.47
CFO/Total Liabilities	-160.14	-74.82	-81.43	-73.53	-36.28	-2.06	-39.88	- -	-304.82	-127.16	-621.32	-233.65	-697.38	-242.13	-76.41
CFO/CapEx	- -	- -	- -	- -	- -	- -	-22.99	- -	-43.74	-27.98	-128.25	-27.32	-33.55	-91.61	-34.71
Altman's Z-Score	-9.03	-121.31	-431.37	-1,581.8	-245.45	-1.04	-661.03	-1,023.18	-118.87	-6.08	9.88	-2.22	-7.9	-21.98	-2.63

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.37	4.2	117.49	39.1	12.62
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	49.52	86.97	3.11	9.34	28.92
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.61	0.6	1.23	1.09	1.63
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	65.02	605.53	296.6	335.41	224.28
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.58	1.16	3.12	3.83	3.48
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	629.84	313.38	116.89	95.33	104.91
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-515.31	379.13	182.82	249.41	148.28
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-15.5	-518.56	-293.5	-326.07	-195.36
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	3	2
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	5	43	25	29	47	27	21	31	44
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	1	- -	- -	- -	4	7	8	5	1	7
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	2	2	- -	1	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	- -	8	45	25	26	41	16	16	29	38
Total Capital	- -	- -	- -	- -	- -	- -	-3	-3	-1	3	7	10	6	1	7
Total Debt/Capital (%)	- -	-7,173	-1,222.17	- -	-20.07	3,065.58	-92.58	-61.67	- -	38.97	4.6	2.07	2.87	24.04	3.64
Total Debt / EV	- -	1.07	0.06	- -	1	-1.11	0.32	0.04	- -	0.05	0.01	0.01	0.01	0.01	0.01
EV/Sales	- -	17.24	394.32	- -	18.35	- -	- -	- -	- -	- -	229.33	96.21	8.28	8.49	4.19
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.3	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.12	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	4	- -	22	21	42	27	16	26	36
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	7	2	22	18	36	19	11	25	29
EV per Share	- -	0.06	1.75	- -	0.05	- -	17.48	84.1	33.31	20.96	20.41	6.09	4.05	5.71	4.57
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	3	9
TTM EBITDA	- -	- -	- -	- -	- -	- -	-3	- -	-6	-5	-10	-10	-12	-12	-4
TTM Operating Income	- -	- -	- -	- -	- -	- -	-3	- -	-6	-5	-10	-10	-12	-12	-4
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	-1	- -	-5	4	-9	-8	-13	-11	-3
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	-1	- -	-5	4	-9	-7	-13	-11	-2

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Price/Free Cash Flow	- -	- -	-18.53	- -	- -	- -	-2.19	- -	-4.21	-6.33	-4.95	-3.73	-1.29	-2.43	-12.94
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	- -	8	45	25	26	41	16	16	29	38
Low Price	- -	- -	0.6	- -	- -	- -	7.5	7.5	31.86	18	14.94	3.06	4.8	3.61	2.37
EV/Sales	- -	17.24	394.32	- -	18.35	- -	- -	- -	- -	- -	229.33	96.21	8.28	8.49	4.19
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-15.22	- -	- -	- -	-0.82	- -	-7.56	-2.36	-6.15	-2.9	-2.1	-2.37	-9.22
Price/Earnings High	- -	- -	-15.22	- -	- -	- -	-0.93	- -	-17.29	-4.45	-14.52	-6.8	-4.39	-4.35	-15.48
Price/Earnings Low	- -	- -	-5.53	- -	- -	- -	-0.54	- -	-3.1	-1.19	-2.68	-0.82	-1.22	-1.31	-4.4
Price/Book Value	- -	- -	-15.35	- -	- -	- -	-1.04	-9.89	-20.39	13.81	7.24	2.85	3.41	37.11	6.28
Price/Book Value Average	- -	- -	-15.35	- -	- -	- -	-0.98	-8.55	-47.13	21.27	10.48	3.06	5.26	40.87	5.85
Price/Book Value High	- -	- -	-15.35	- -	- -	- -	-1.11	-21.97	-107.83	40.15	24.74	7.18	10.99	74.98	9.83
Price/Book Value Low	- -	- -	-5.58	- -	- -	- -	-0.65	-0.92	-19.3	10.74	4.56	0.86	3.06	22.56	2.79
Price/Tangible Book Value	- -	- -	-15.35	- -	- -	- -	-1	-9.45	-17.81	14.94	7.39	2.89	3.46	40.42	6.32
Price/Tangible Book Value Average	- -	- -	-15.35	- -	- -	- -	-0.94	-8.18	-41.18	23.01	10.7	3.1	5.34	44.51	5.89
Price/Tangible Book Value High	- -	- -	-15.35	- -	- -	- -	-1.06	-21.01	-94.22	43.44	25.26	7.26	11.15	81.66	9.89
Price/Tangible Book Value Low	- -	- -	-5.58	- -	- -	- -	-0.62	-0.88	-16.86	11.62	4.66	0.87	3.11	24.57	2.81
Price/Sales	- -	- -	372.32	- -	- -	- -	- -	- -	- -	- -	237.18	157.96	8.26	7.67	3.92
Price/Sales Average	- -	- -	372.32	- -	- -	- -	- -	- -	- -	- -	343.42	169.4	12.76	8.45	3.65
Price/Sales High	- -	- -	372.32	- -	- -	- -	- -	- -	- -	- -	810.61	397.23	26.64	15.5	6.13
Price/Sales Low	- -	- -	135.39	- -	- -	- -	- -	- -	- -	- -	149.51	47.67	7.43	4.66	1.74
Price/Cash Flow	- -	- -	-18.53	- -	- -	- -	-2.09	- -	-4.11	-6.1	-4.91	-3.6	-1.25	-2.41	-12.57
Price/Cash Flow Average	- -	- -	-18.53	- -	- -	- -	-1.97	- -	-9.5	-9.4	-7.11	-3.86	-1.93	-2.65	-11.72
Price/Cash Flow High	- -	- -	-18.53	- -	- -	- -	-2.22	- -	-21.73	-17.74	-16.79	-9.04	-4.04	-4.86	-19.67
Price/Cash Flow Low	- -	- -	-6.74	- -	- -	- -	-1.31	- -	-3.89	-4.74	-3.1	-1.09	-1.12	-1.46	-5.59
Price/Free Cash Flow Average	- -	- -	-18.53	- -	- -	- -	-2.06	- -	-9.72	-9.74	-7.17	-4	-1.99	-2.68	-12.07
Price/Free Cash Flow High	- -	- -	-18.53	- -	- -	- -	-2.32	- -	-22.24	-18.4	-16.92	-9.39	-4.16	-4.91	-20.25
Price/Free Cash Flow Low	- -	- -	-6.74	- -	- -	- -	-1.37	- -	-3.98	-4.92	-3.12	-1.13	-1.16	-1.48	-5.76
EV/Sales Average	- -	17.24	394.32	- -	18.35	- -	- -	- -	- -	- -	348.62	125.22	14.22	9.38	3.86
EV/Sales High	- -	17.24	394.32	- -	18.35	- -	- -	- -	- -	- -	873.16	356.16	32.54	17.5	6.95
EV/Sales Low	- -	17.24	157.39	- -	18.35	- -	- -	- -	- -	- -	130.9	1.83	7.17	5.02	1.48
EV/EBITDA Average	0.5	-1.16	-19.63	0.01	-0.44	7.57	-2.41	- -	-10.04	-8.49	-6.13	-2.16	-2.36	-2.78	-8.85
EV/EBITDA High	0.5	-1.16	-19.63	0.01	-0.44	7.57	-2.61	- -	-23.02	-16.53	-15.34	-6.15	-5.4	-5.19	-15.94
EV/EBITDA Low	0.5	-1.16	-7.83	0.01	-0.44	7.57	-1.86	- -	-4.08	-4.01	-2.3	-0.03	-1.19	-1.49	-3.39
EV/EBIT Average	0.5	-1.16	-19.63	0.01	-0.44	7.57	-2.39	- -	-9.99	-8.41	-6.08	-2.14	-2.32	-2.73	-8.31
EV/EBIT High	0.5	-1.16	-19.63	0.01	-0.44	7.57	-2.59	- -	-22.91	-16.37	-15.22	-6.08	-5.31	-5.08	-14.95
EV/EBIT Low	0.5	-1.16	-7.83	0.01	-0.44	7.57	-1.85	- -	-4.06	-3.97	-2.28	-0.03	-1.17	-1.46	-3.18
Last Price	- -	- -	1.65	- -	- -	- -	12	81	33.66	23.16	23.7	10.14	5.34	5.94	5.33
High Price	- -	- -	1.65	- -	- -	- -	12.75	180	178.02	67.32	81	25.5	17.22	12	8.34
Enterprise Value Average	- -	- -	- -	- -	- -	- -	7	39	58	41	62	21	28	32	35
Enterprise Value High	- -	- -	- -	- -	- -	- -	8	98	133	80	156	61	64	60	63
Enterprise Value Low	- -	- -	- -	- -	- -	- -	6	6	24	19	23	- -	14	17	13

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	1	1	1	2	3	4	5	8
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2	3	3	4	7
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2	3	3	4	7
Revenue per Share	0.02	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.1	0.06	0.65	0.77	1.36
EBITDA per Share	-0.11	-0.05	-0.09	-0.13	-0.11	-0.12	-8.32	- -	-8.78	-5.38	-5.69	-3.72	-3.89	-2.61	-0.59
Operating Income per Share	-0.11	-0.05	-0.09	-0.13	-0.11	-0.12	-8.37	- -	-8.82	-5.43	-5.73	-3.76	-3.96	-2.67	-0.63
Basic EPS, GAAP	-0.11	-0.05	-0.11	-0.13	-0.22	-0.17	-13.77	- -	-10.29	-15.11	-5.58	-3.75	-3.93	-2.76	-0.54
Basic EPS from Cont Ops	-0.11	-0.05	-0.11	-0.13	-0.11	-0.12	-13.77	- -	-10.29	-15.11	-5.58	-3.75	-3.93	-2.76	-0.54
Diluted EPS, GAAP	-0.11	-0.05	-0.11	-0.13	-0.22	-0.17	-13.77	- -	-10.29	-15.11	-5.58	-3.75	-3.93	-2.76	-0.54
Diluted EPS from Cont Ops	-0.11	-0.05	-0.11	-0.13	-0.11	-0.12	-13.77	- -	-10.29	-15.11	-5.58	-3.75	-3.93	-2.76	-0.54
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.11	-0.05	-0.09	-0.09	-0.11	-0.07	-5.74	- -	-8.19	-3.8	-4.83	-2.82	-4.27	-2.47	-0.42
Free Cash Flow per Basic Share	-0.11	-0.05	-0.09	-0.09	-0.11	-0.07	-5.99	- -	-8.38	-3.93	-4.86	-2.92	-4.39	-2.5	-0.44
Cash & Equivalents per Share	0.05	- -	- -	- -	- -	1.85	0.06	0.02	0.35	3.28	3.45	4.12	1.33	0.28	0.79
Book Value per Share	-0.01	-0.06	-0.11	-0.13	-0.29	-0.94	-11.53	-8.19	-1.65	1.68	3.27	3.55	1.57	0.16	0.85
Tangible Book Value per Share	-0.01	-0.06	-0.11	-0.13	-0.29	-1.59	-12.02	-8.57	-1.89	1.55	3.21	3.51	1.54	0.15	0.84

NeuroOne Medical Technologies Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)